New Foundations

Increases in life expectancy and declining fertility are driving growth in both the number and proportion of older people globally. Some fear that ageing populations will put ever greater pressure on health systems, social care, housing and public finances. But should we be thinking differently about ageing? Is there an opportunity in a so-called silver economy? In this episode we explore how technology can support people to age better while reducing the burden on health systems, how longer lives call for a reimagining of our economy and society, and how frontier science is finding ways to further lengthen our life spans. With The EIU's Jeremy Kingsley and Elizabeth Sukkar, Andrew Scott from The London Business School, Lorenzo Chiari from the University of Bologna, and Michael Hufford, chief executive of biotech firm LyGenesis. This podcast is supported by Pictet Wealth Management and includes additional commentary from equity strategist Alexandre Tavazzi.

Disclaimer: The findings and views expressed in the podcast are for information only and are not intended as an offer or solicitation or any legal, tax or financial advice. Whilst efforts have been taken to verify the accuracy of this information, neither The Economist Intelligence Unit Ltd., nor its affiliates, nor the Pictet Group can accept any responsibility or liability for the use of, or reliance by any person on, the information contained in this podcast. The findings and views expressed in the report do not necessarily reflect the views of the Pictet Group. The content of this podcast is not intended for persons who are cit­izens of, domiciled or resident in, or entities registered in a country or a jurisdiction in which its distribution, publication, provision or use would violate current laws and regulations.

Hosted on Acast. See acast.com/privacy for more information.

Proponents of a burgeoning education technology or 'ed tech' sector say digital learning platforms can radically transform how education is delivered, bringing a far better education to far more people—and help solve a global learning crisis. But adoption has been slow, with classrooms today little different from how they were half a century ago. Will the experiences of remote teaching and learning, enforced by covid-19, speed up innovation in the sector—or have they exposed flaws in the idea? We explore with technologists, researchers and educators. This podcast is supported by Pictet Wealth Management.

Disclaimer: The findings and views expressed in the podcast are for information only and are not intended as an offer or solicitation or any legal, tax or financial advice. Whilst efforts have been taken to verify the accuracy of this information, neither The Economist Intelligence Unit Ltd., nor its affiliates, nor the Pictet Group can accept any responsibility or liability for the use of, or reliance by any person on, the information contained in this podcast. The findings and views expressed in the report do not necessarily reflect the views of the Pictet Group. The content of this podcast is not intended for persons who are cit­izens of, domiciled or resident in, or entities registered in a country or a jurisdiction in which its distribution, publication, provision or use would violate current laws and regulations.

Hosted on Acast. See acast.com/privacy for more information.

Modern medicine has a problem: despite impressive advances in technology, progress in drug development has slowed since the 1950s, as discovering and trialling new therapies has become more complex and expensive.

In this episode we explore how a convergence of healthcare technologies, and in particular artificial intelligence, promise to speed up and lower the cost of drug discovery and development—and the implications for medical breakthroughs and the economics of healthcare.

With guests Andrew Hopkins of Exscientia, Carina Namih of Episode1 Ventures, Peter Richardson of BenevolentAI, and industry advisor Steve Lipset.

Disclaimer: The findings and views expressed in the podcast are for information only and are not intended as an offer or solicitation or any legal, tax or financial advice. Whilst efforts have been taken to verify the accuracy of this information, neither The Economist Intelligence Unit Ltd., nor its affiliates, nor the Pictet Group can accept any responsibility or liability for the use of, or reliance by any person on, the information contained in this podcast. The findings and views expressed in the report do not necessarily reflect the views of the Pictet Group. The content of this podcast is not intended for persons who are cit­izens of, domiciled or resident in, or entities registered in a country or a jurisdiction in which its distribution, publication, provision or use would violate current laws and regulations.

Hosted on Acast. See acast.com/privacy for more information.

Experts warn that growing demand for food, and particularly for meat, cannot be met sustainably. Advances in synthetic biology and precision fermentation could allow us to replace fundamental sources of protein with lab-grown substitutes—feeding many more with much less. But is technological innovation enough to determine change in what we eat? How will consumers, industry incumbents and policymakers, shape how such technology is used? 

We explore with the technologists at Finnish food-tech startup Solar Foods, and guests George Monbiot and Catherine Tubb.

Disclaimer: The findings and views expressed in the podcast are for information only and are not intended as an offer or solicitation or any legal, tax or financial advice. Whilst efforts have been taken to verify the accuracy of this information, neither The Economist Intelligence Unit Ltd., nor its affiliates, nor the Pictet Group can accept any responsibility or liability for the use of, or reliance by any person on, the information contained in this podcast. The findings and views expressed in the report do not necessarily reflect the views of the Pictet Group. The content of this podcast is not intended for persons who are cit­izens of, domiciled or resident in, or entities registered in a country or a jurisdiction in which its distribution, publication, provision or use would violate current laws and regulations.

Hosted on Acast. See acast.com/privacy for more information.

See acast.com/privacy for privacy and opt-out information.